.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Recombinant Antibodies for Cancer Therapy
. Ed(S): Welschof, Martin; Krauss, Jurgen
€ 196.93
FREE Delivery in Ireland
Description for Recombinant Antibodies for Cancer Therapy
Hardback. Presents a collection of protocols for the design, construction, and characterization of novel anticancer therapeutics based on recombinant antibody technology. This title contains reproducible methods that include coverage of hybridoma-derived recombinant antibodies and recombinant antibody fragments from phagemid-displayed antibody repertoires. Editor(s): Welschof, Martin; Krauss, Jurgen. Series: Methods in Molecular Biology. Num Pages: 481 pages, biography. BIC Classification: MJCL; PDN; PSD. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 26. Weight in Grams: 874.
Since the advent of hybridoma technology more than two decades ago, numerous antibodies have entered the clinical setting as potent therapeutic agents. Their repeated application in humans, however, is limited by the development of human antimouse antibodies (HAMA) in the recipient, leading to allergic re- tions against the foreign murine protein and rapid neutralization. To circumvent these limitations many new antibodies have recently been tailored through recombinant antibody technology. The initial clinical data show encouraging results, thus demonstrating the potential of these new therapeutic agents. The purpose of Recombinant Antibodies for Cancer Therapy is to present a collection of detailed ... Read more
Since the advent of hybridoma technology more than two decades ago, numerous antibodies have entered the clinical setting as potent therapeutic agents. Their repeated application in humans, however, is limited by the development of human antimouse antibodies (HAMA) in the recipient, leading to allergic re- tions against the foreign murine protein and rapid neutralization. To circumvent these limitations many new antibodies have recently been tailored through recombinant antibody technology. The initial clinical data show encouraging results, thus demonstrating the potential of these new therapeutic agents. The purpose of Recombinant Antibodies for Cancer Therapy is to present a collection of detailed ... Read more
Product Details
Format
Hardback
Publication date
2002
Publisher
Humana Press Inc. United States
Number of pages
481
Condition
New
Series
Methods in Molecular Biology
Number of Pages
481
Place of Publication
Totowa, NJ, United States
ISBN
9780896039186
SKU
V9780896039186
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Recombinant Antibodies for Cancer Therapy
"...the book is well written and the experimental protocols that were included are described in great detail...this book is a valuable resource both for persons new to this field to get an overview of current activities and for those already in the field to look up specific areas that are covered." -Clinical Immunology ... Read more